• Natera appointed Solomon Moshkevich CEO and a director, effective immediately, replacing Steve Chapman.
• Moshkevich joined in 2011 and most recently served as president, clinical diagnostics. He previously led the oncology business.
• Chapman will serve as a consultant for an extended period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611051606BIZWIRE_USPR_____20261105_BW628208) on November 05, 2026, and is solely responsible for the information contained therein.